- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 7, 2026 | 134.62M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 124.04M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 54.51M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $10.57M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$15.31M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $113.06M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $0 |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $743.5M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $589.77M |
| Stockholders Equity restated | Q3 2026 · Sep 30, 2025 | −$13.7M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$597K |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $6.44M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $597K |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $66.91M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $597K |
| Current Assets | Q3 2026 · Mar 31, 2026 | $117.41M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $0 |
| Total Assets | Q3 2026 · Mar 31, 2026 | $810.41M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $0 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $1.01 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$3.03 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $1.01 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$3.03 |
| Net Income | Q3 2026 · Mar 31, 2026 | $152.51M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$165.35M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$304.46M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$13.4M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $193.81M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$107.13M |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.63M |
| Revenue | Q3 2026 · Mar 31, 2026 | $3.13M |